Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 97 5-Year Yield-on-Cost % is 8.51 as of Aug. 12, 2026, which is 113% above its 10-year median of 4.00. GuruFocus rates SAU:4002 with a GF Score™ of 97/100 and a GF Value™ of ﷼109.40 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks better than 89.45% on this metric.
The historical rank and industry rank for Mouwasat Medical Services Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SAU:4002'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.64 Med: 4 Max: 12.76
Current: 8.51
During the past 13 years, Mouwasat Medical Services Co's highest Yield on Cost was 12.76. The lowest was 2.64. And the median was 4.00.
SAU:4002's 5-Year Yield-on-Cost % is ranked better than 89.45% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs SAU:4002: 8.51
Mouwasat Medical Services Co (SAU:4002) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Mouwasat Medical Services Co 5-Year Yield-on-Cost % Related Terms
SAU:4002 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's 5-Year Yield-on-Cost % falls into.
Mouwasat Medical Services Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Mouwasat Medical Services Co (SAU:4002) has a 5-Year Yield-on-Cost % of 8.51 as of Aug. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mouwasat Medical Services Co and its competitors. This is 113% above median its historical median of 4.00. Over the past decade, Mouwasat Medical Services Co's 5-Year Yield-on-Cost % has ranged from 2.64 to 12.76. According to the industry distribution chart, Mouwasat Medical Services Co ranks #29 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 10.5%.
Is Mouwasat Medical Services Co's 5-Year Yield-on-Cost % too high?
Mouwasat Medical Services Co's current 5-Year Yield-on-Cost % of 8.51 is 113% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.64 to a high of 12.76. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Mouwasat Medical Services Co's value of 8.51 is 193.4% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #29 out of 275 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Mouwasat Medical Services Co has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #29 out of 275 companies for 5-Year Yield-on-Cost %. This places Mouwasat Medical Services Co in the top 11% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.90. Mouwasat Medical Services Co's value of 8.51 is 193.4% above this benchmark. Historically, Mouwasat Medical Services Co's own 5-Year Yield-on-Cost % has ranged from 2.64 to 12.76 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 2.90, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current 5-Year Yield-on-Cost % of 8.51 is 193.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current 5-Year Yield-on-Cost % is 8.51, which is 113% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.40, compared to a current price of ﷼63.95 — trading 41.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 8.51, which is 113% above median its 10-year median of 4.00 and 193.4% above the Healthcare Providers & Services industry median of 2.90. Mouwasat Medical Services Co's overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current 5-Year Yield-on-Cost % is 8.51 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼63.95 is trading 41.5% below its estimated GF Value™ of ﷼109.40.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
5-Year Yield-on-Cost %: 8.51 (113% above median its 10-year median of 4.00)
GF Value™: ﷼109.40 vs. price of ﷼63.95 (41.5% below fair value)
Industry Position: 193.4% above the Healthcare Providers & Services median (#29 of 275)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
97GF Score
Get the complete analysis for SAU:4002
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
